Riis, B.J., Rødbro, O., Christiansen, C., The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis (1986) Calcif. Tissue Int., 38, pp. 318-322
Lindsay, R., Hart, D.M., Forrest, C., Baird, C., Prevention of spinal osteoporosis in oophorectomized women (1980) Lancet, 2, pp. 1151-1153
Christiansen, C., Christensen, M.S., McNair, P., Hagen, C., Stocklund, K.-E., Transbøl, I., Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females (1980) Eur. J. Clin. Invest., 10, pp. 273-279
Horsman, A., Jones, M., Francis, R., Nordin, C., The effect of estrogen dose on postmenopausal bone loss (1983) N. Engl. J. Med., 309, pp. 1405-1407
Copp, D.H., Cameron, E.C., Cheney, B.A., Davidson, A.G., Henze, K.G., Evidence for calcitonin, a new hormone from the parathyroid that lowers blood calcium (1973) Endocrinology, 70, pp. 638-649
Lucht, Y., Effects of calcitonin on osteoclasts in vivo. An ultra-structural and histochemical study (1973) Z. Zellforsch., 145, pp. 75-87
Reginster, J.-Y., Franchimont, P., La calcitonin 25 ans après (1985) Méd. et Hyg., 43, pp. 3808-3814
Gennari, C., Chierichetti, S.M., Bigazzi, S., Fusi, C., Gonnelli, S., Ferrara, R., Zacchei, F., Comparative effects on bone mineral content of calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis (1985) Curr. Ther. Res., 38, pp. 455-464
Mazzuoli, G.F., Passeri, M., Gennari, C., Minisola, S., Antonelli, R., Voltorta, C., Palummeri, E., Francini, G., Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double blind clinical study (1986) Calcif. Tissue Int., 38, pp. 3-8
Gennari, C., Cecchetin, M., Passeri, M., Francini, G., Gonnelli, S., Nami, R., Bigazzi, S., Gli effetti collaterali di differente calcitonine (1983) Calcitonin in Man, pp. 93-101. , Eds. C. Gennari, G. Segre. Masson Publ., Milan
Fink, G., Gennser, G., Liedholm, P., Thoreil, J., Comparison of plasma levels of LH-RH in men after intravenous and intranasal administration (1974) J. Endocrinol., 63, pp. 351-360
Pontiroli, A.E., Alberetto, M., Secchi, A., Dossi, G., Bosi, I., Pozza, G., Insulin given intranasally induces hypocalcaemia in normal and diabetic subjects (1982) Br. Med. J., 284, pp. 303-306
Pontiroli, A.E., Alberetto, M., Pozza, G., Intranasal glucagon raises blood glucose concentration in healthy volunteers (1983) Br. Med. J., 287, pp. 462-463
Murlin, J.R., Gibb, C.B.F., Romansky, M.J., Steinhausen, T.B., Truax, F.L., Effectiveness of perioral insulin in human diabetes (1940) Am. J. Physiol., 120, pp. 709-722
Reginster, J.-Y., Albert, A., Franchimont, P., Salmon calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients (1985) Calcif. Tissue Int., 37, pp. 557-580
Niall, H.D., Keutmann, H.T., Copp, D.H., Potts, J.J., Amino-acid sequence of salmon ultimobranchial calcitonin (1986) Proc. Natl. Acad. Sci. USA, 64, pp. 771-778
Hosking, D.J., Denton, L.B., Cadge, B., Martin, J.J., Functional significance of antibody formation after long-term salmon calcitonin therapy (1979) Clin. Endocrinol., 10, pp. 243-252
Singer, F.R., Aired, J.C., Neer, R.M., Krane, S.M., Potts, J.T., Bloch, K.J., An evaluation of antibodies and clinical resistance to salmon calcitonin (1972) J. Clin. Invest., 51, pp. 2331-2338
Hillyard, C.J., Stevenson, J.C., McIntyre, I., Relative deficiency of plasma calcitonin in normal women (1978) Lancet, 2, pp. 961-962
Tiegs, R.D., Body, J.J., Barta, J.M., Heath, H., Secretion and metabolism of monomeric human calcitonin: effects of age, sex and thyroid damage (1986) J. Bone Min. Res., 1, pp. 339-349
Lorè, F., Galli, M., Franci, B., Martorelli, M.T., Calcitonin levels in normal subjects according to age and sex (1984) Biomed. Pharmacother., 38, pp. 261-263
Stevenson, J.C., Abeyasekara, G., Hillyard, C.J., Phang, K.G., McIntyre, I., Campbell, S., Lane, G., Whitehead, M.I., Regulation of calcium-regulatory hormones by exogenous sex steroids in early menopause (1983) Eur. J. Clin. Invest., 13, pp. 481-487
Kanis, J.A., Heynen, G., Cundy, T., Cornet, F., Paterson, A., Russel, R.G.G., An estimate of the endogenous secretion rate of calcitonin in man (1982) Clin. Sci., 63, pp. 145-152
Singer, F.R., Fredericks, R.S., Minkin, C., Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired resistance (1980) Arth. Rheum., 23, pp. 1148-1153
Derose, J., Singer, F.R., Avramides, A., Flores, A., Dziadiw, R., Baker, R.K., Wallach, S., Response of Paget's disease to porcine and salmon calcitonin (1974) Am. J. Med., 56, pp. 850-856
Greenberg, P.B., Doyle, F.M., Fisher, M.T., Hillyard, C.J., Joplin, G.F., Pennock, J., McLntyre, I., Treatment of Paget's disease of bone with synthetic human calcitonin (1974) Am. J. Med., 56, pp. 867-870
Azria, M., Attinger, M., Schupfer, H., Tanner, P., Comparison of the hypocalcaemic activities of three calcitonins using a new biological method (1985) Calcitonin 1984, pp. 104-110. , Ed. W. Doepfrer. Excerpta Medica, Amsterdam, Hong-Kong, Princeton, Sidney and Tokyo
Reginster, J.-Y., Franchimont, P., Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection (1985) Clin. Exp. Rheum., 3, pp. 155-157
Reginster, J.-Y., Denis, D., Albert, A., Franchimont, P., Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SCT) by comparison with intramuscular or placebo injection in normal subjects (1987) Bone Min., 2, pp. 133-140
Meunier, P.J., La maladie osseuse de Paget. Histologic quantitative et prescription thérapeutique (1975) Lyon Med., 233, pp. 839-853
Kanis, J.A., Gray, R.E., Long-term follow-up observations on treatment in Paget's disease of bone (1987) Clin. Orth. Rel. Res., 217, pp. 99-125
Reginster, J.-Y., Jeugmans-Huynen, A.M., Albert, A., Denis, D., Franchimont, P., One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray (1988) J. Bone Min. Res., 3, pp. 249-252
Reginster, J.-Y., Denis, D., Albert, A., Deroisy, R., Lecart, M.P., Fontaine, M.A., Lambelin, P., Franchimont, P., 1-year controlled randomized trial of prevention of early postmenopausal bone loss by intranasal calcitonin (1987) Lancet, 2, pp. 1481-1483
